Athenex Announces FDA Allowance of Investigational New Drug Application of Eribulin ORA to Begin Clinical Trials Pharmaceutical Investing
VistaGen Therapeutics Acquires Worldwide Rights to Develop and Commercialize PH10 Pharmaceutical Investing
Ovid Therapeutics Presents Additional Data and Analyses from the Phase 2 STARS Clinical Trial with OV101 Pharmaceutical Investing
Forward Pharma Provides Update on the Decision of the Federal Circuit in its Appeal of the U.S. Patent Interference Life Science Investing
BeiGene Announces Acceptance of its New Drug Application in China and Top-Line Pivotal Data for Zanubrutinib Pharmaceutical Investing
Xanthic Biopharma Inc. Issues News Release Clarifying Management Information Circular of October 12, 2018 Cannabis Investing News
Alder BioPharmaceuticals Announces Positive Results From Pharmacokinetic Comparability Study for Eptinezumab Pharmaceutical Investing
Tetraphase Pharmaceuticals Announces Positive Data from Post-Hoc Analysis of Phase 3 Trials Pharmaceutical Investing
